Trastuzumab Active Not Recruiting Phase 2 Trials for Metastatic Breast Cancer (MBC) Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Active Not Recruiting | Treatment | 2 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT02536339 | Pertuzumab With High-Dose Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progression Post-Radiotherapy | |
NCT01835236 | Trastuzumab & Pertuzumab Followed by T-DM1 in MBC | |
NCT00431704 | VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer |